Psychopharmacology of conduct disorder: current progress and future directions

Bibliography

• KAZDIN A: Treatment for aggressive and antisocial children. Child Adolesc. Psychiatr. Clin. N Am. (2000) 9:841–858.
   PubMed Web of Science ®Google Scholar
• AMERICAN PSYCHIATRIC ASSOCIATION. In: Text Revision. Diagnostic and Statistical Manual of Mental Disorders (4th edit). American Psychiatric Association, Washington, DC (2000).
   Google Scholar
• ROBINS LN: Deviant children grown up. Williams and Wilkins, Baltimore, USA (1966).
   Google Scholar
• FINDLING RL: Paediatric psychopharmacology: closing the gap between science and practice. Expert Opin. Pharmacother: (2001) 2(4):523–525.
   PubMedGoogle Scholar
• LOEBER R, HAY D: Key in the development of aggression and violence from childhood to early adulthood. Ann. Rev Psychol (1997) 48:371–410.
   PubMed Web of Science ®Google Scholar
• AGNOLD A, COSTELLO EJ, ERKANI A: Comorbidity. I Child Psycho]. Psychiatry(1999) 40(1):57–87.
   PubMed Web of Science ®Google Scholar
• WORLD HEALTH ORGANISATION: ICD-I0. Classification of Mental and Behavioural Disorders. Clinical Description and Diagnostic Guidelines. World Health organization (WHO) Geneva (1992).
   Google Scholar
• HILL J: Biological, psychological and social processes in the conduct disorders. I. Clin. Psycho.] Psychiatry (2002) 43:133–164.
   PubMed Web of Science ®Google Scholar
• ••An excellent review of different factorsinvolved in CD.
   Google Scholar
• PLOMIN R, OWEN, MJ, MCGUFFIN P: The genetic basis of complex human behavior. Science (1994) 264:1733–1739.
   PubMed Web of Science ®Google Scholar
• CASPI A, McCLAYJ, MOFFITT TE et al: Role of genotype in the cycle of violence in maltreated children. Science (2002) 297:851–854.
   PubMed Web of Science ®Google Scholar
• BIEDERMAN J, FARAONE SV, MILBERGER S et al: Is childhood oppositional defiant disorder a precursor to adolescent conduct disorder? Findings from a four-year follow-up study of children with ADHD. jAm. Acad. Child Adolesc. Psychiatry (1996) 35:1193–1204.
   PubMed Web of Science ®Google Scholar
• ZOCCOLILLO M, PICKLES A, QUINTAN D, RUTTER M: The outcome of childhood conduct disorder: implications for defining adult personality disorder and conduct disorder. Psycho]. Med. (1992) 22:971–986.
   PubMed Web of Science ®Google Scholar
• WADDEL C, LIPMAN E, OFFORD D: Conduct disorder: practice parameters for assessment, treatment, and prevention. Can. J. Psychiatry (1999) 44\(Suppl. 2)355–405.
   Google Scholar
• CAMPBELL M, GONZALEZ NM, SILVA RR: The pharmacologic treatment of conduct disorders and rage outbursts. Psychiatr. Clin. N Am. (1992) 15(1):69–85.
   PubMed Web of Science ®Google Scholar
• ••A biological approach to the treatmentof CD.
   Google Scholar
• KAPLAN SL, SIMMS RM, BUSNER J: Prescibing practices of out-patient child psychiatrists. I Am. Acad. Child Adolesc. Psychiatry (1994) 33:35–44.
   PubMed Web of Science ®Google Scholar
• PAPPADOPULUS E, MACINTYRE II JC, CRISMON ML et al.: Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part 11.j Am. Acad. Child Adolesc. Psychiatry (2003) 42:145–161.
   Google Scholar
• CAMPBELL M, SMALL AM, GREEN WH et al.: Behavioral efficacy of haloperidol and lithium carbonate: a comparison in hospitalized aggressive children with conduct disorder. Arch. Gen. Psychiatry (1984) 41:650–656.
   PubMed Web of Science ®Google Scholar
• GREENHILL LL, SOLOMON M, PLEAK R, AMBROSINI P: Molindone hydrochloride treatment of hospitalized children with conduct disorder. I. Clin. Psychiatry (1985) 46(8):20–25.
   PubMed Web of Science ®Google Scholar
• WHITAKER A, RAO U: Neuroleptics in pediatric psychiatry. Psychiatr. Clin. N Am. (1992) 15(1):243–276.
   PubMed Web of Science ®Google Scholar
• CAMPBELL M, ADAMS P, PERRY R et al.: Tardive and withdrawal dyskinesia in autistic children. A prospective study. Psychopharmacol Bull. (1988) 24:251–255.
   PubMedGoogle Scholar
• KUMRA S, FRAZIER JA, JACOBSEN LK et al.: Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison. Arch. Gen. Psychiatry(1998) 55:90–92.
   PubMed Web of Science ®Google Scholar
• SIKICH L, HAMER RM, BASHFORD RA, SHEITMAN BB, LIEBERMAN IA: A pilot study of risperidon, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial. Neuropsychopharmacology (2004) 29:133–145.
   PubMed Web of Science ®Google Scholar
• BUITELAAR JK, VAN DER GAAG RJ, COHEN-KETTENIS P, MELMAN CT: A randomized controlled trail of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities. I. Clin. Psychiatry (2001) 5(1): 239–248.
   Google Scholar
• SNYDER R, TURGAY A, AMAN M, BINDER C, FISMAN S, CAROLL A: Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. Am. Acad. Child Adolesc. Psychiatry (2002) 41:1026–1036.
   PubMed Web of Science ®Google Scholar
• FINDLING RL, MCNAMARA NK, BRANIKY LA, SCHUCHTER MD, LEMON E, BLUMERJ: A double-blind pilot study of risperidone in the treatment of conduct disorder. I Am. Acad. Child Psychiatry (2000) 39(4):509–516.
   PubMed Web of Science ®Google Scholar
• FINDLING RL: Aripiprazole reduces aggressive behavior in children. Proceedings of the I ffh US Psychiatric and Mental Health Congress. Orlando, USA (2003) Abstract 33.
   Google Scholar
• MICZEK KA: The psychopharmacology of aggression. In: Handbook of Psychopharmacology: New directions in Behavioral Pharmacology Iversen LL, Iversen SD, Snyder SH (Eds), Plenium, New York, USA (1987):183–328.
   Google Scholar
• EICHELMAN B: Aggressive behavior: from laboratory to clinic: quo vadit? Arch. Gen. Psychiatry (1992) 49:488–492.
   PubMed Web of Science ®Google Scholar
• SHEARD MH: Effect of lithium on human aggression. Nature (1971) 230:113–114.
   PubMed Web of Science ®Google Scholar
• ••One of the first descriptions of aspecific role of lithium therapy for human aggression.
   Google Scholar
• SHEARD MH, MARINI IL: Treatment of human aggressive behavior: four case studies of the effect of lithium. Compr: Psychiatry (1978) 19:37–45.
   PubMed Web of Science ®Google Scholar
• SHEARD MH, MARINI JL, BRIDGES CL, WAYNER E: The effects of lithium on impulsive aggressive behavior in man. Am. I Psychiatry (1976) 133:1409–1413.
   PubMed Web of Science ®Google Scholar
• DALE PG: Lithium therapy in aggressive mentally subnormal patients. Br. Psychiatry (1980) 137:469–474.
   PubMed Web of Science ®Google Scholar
• DELONG GR, ALDERSHOF AL: Long-term experience with lithium treatment in childhood: correlation with clinical diagnosis. j. Am. Acad. Child Adolesc. Psychiatry (1987) 26:389–394.
   PubMed Web of Science ®Google Scholar
• CAMPBELL M, ADAMS PB, SMALL AM et al.: Lithium in hospitalized aggressive children with conduct disorder: a double-blind and placebo-controlled study. Am. Acad. Child Adolesc. Psychiatry (1995) 34:445–453.
   PubMed Web of Science ®Google Scholar
• MALONE RP, DELANEY JF, CARTER J, CAMPBELL M: A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder. Arch. Gen. Psychiatry (2000) 57:649–654.
   PubMed Web of Science ®Google Scholar
• ••Recent data suggesting that lithiumtherapy is an effective treatment for CD in in-patient populations.
   Google Scholar
• RIFKIN A, KARAJGI B, DICKER R et al.: Lithium treatment of conduct disorder in adolescents. Am. .1. Psychiatry (1997) 154(4): 554–555.
   Google Scholar
• STEINER H, PETERSON ML, SAXENA K, FORD, MATTEWS Z: Divalproex sodium for the treatment of conduct disorder: a randomized controlled clinical trial. Clin. Psychiatry (2003) 64(10): 1183–1191.
   PubMed Web of Science ®Google Scholar
• GROH C: The psychotropic effect of Tegretol in non-epileptic children, with particular reference to the drug's indication. In: Epileptic Seizures-Behaviour-Pain. Birkmayer W (Ed.), University Park Press, Baltimore, MD, USA (1976):259–263.
   Google Scholar
• PUENTE RM: The use of carbamazepine in the treatment of behavioural disorders in children. In: Epileptic Seizures-Behaviour-Pain. Birkmayer W (Ed.), University Park Press, Baltimore, MD, USA (1976):243–247.
   Google Scholar
• KAFANTARIS V, CAMPBELL M, PADRON-GAYOL MV, SMALL AM, LOCASCIO JJ, ROSENBERG CR: Carbamazepine in hospitalized aggressive conduct disorder children: an open pilot study. Psychopharmacol Bull. (1992) 28:193–199.
   PubMedGoogle Scholar
• CUEVA JE, OVERALL JE, SMALL AM, ARMENTEROS JL, PERRY R, CAMPBELL M: Carbamazepine in aggressive children with conduct disorder: a double-blind and placebo-controlled study. I Am. Acad. Child Adolsc. Psychiatry (1996) 35(4):480–490.
   PubMed Web of Science ®Google Scholar
• KLEIN RG, ABIKOFF H, KLASS E, GANELES D, SEESE LM, POLLACK S: Clinical efficacy of methylphenidate in conduct disorder with and without attention hyperactivity deficit hyperactivity disorder. Arch. Gen. Psychiatry(1997) 54(12):1073–1080.
   PubMed Web of Science ®Google Scholar
• CONNOR DF, BARKLEY RA, DAVIS HT: A pilot study of methylphenidate, clonidine, or the combination of both in ADHD comorbid with aggressive oppositional defiant or conduct disorder. Clin. Pediatr. (2000) 39(1):15–25.
   PubMed Web of Science ®Google Scholar
• HAZEL PL, STUART JE: A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children. I Am. Acad. Child Adolesc. Psychiatry (2003) 42(8):886–894.
   PubMed Web of Science ®Google Scholar
• RIGGS PD, LEON SL, MIKULICH SK, POTTLE LC: An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder. Acad. Child Adolesc. Psychiatry (1998) 37(12):1271–1278
   PubMed Web of Science ®Google Scholar
• CLINGEMPEEL WG, HENGGELER SW: Randomized clinical trials, developmental theory, and antisocial youth: Guidelines for research. Dev Psychopathol (2002) 14:695–711.
   PubMed Web of Science ®Google Scholar
• •Methodological issues surrounding the clinical trials in CD population.
   Google Scholar
• ZITO JM, SAFER DJ, DOSREIS S et al.: Psychotropic practice patterns for youth: a 10-year perspective. Arch. Pediatr. Adolesc. Med. (2003) 157:17–25.
   PubMed Web of Science ®Google Scholar
• WIZNITZER M, FINDLING RL: Why do psychiatric drug research in children? Lancet (2003) 361:1147–1148.
   PubMed Web of Science ®Google Scholar
• CARREY N: Developmental neurobiology implications for pediatric psychopharmacology. Can.j Psychiatry (2001) 46:810–818.
   PubMed Web of Science ®Google Scholar
• VITIELLO B: Psychopharmacology for young children: clinical needs and research opportunities. Pediatrics (2001) 108:983–989.
   PubMed Web of Science ®Google Scholar
• US DEPARTMENT OF HEALTH AND HUMAN SERVICES: Youth violence: a report of the surgeon general. Centers for Disease Control and Prevention, Substance Abuse and Mental Health Services Administration, National Institutes of Health, National Institute of Mental Health. Rockville, MD, USA (2001).
   Google Scholar
• HYMAN SE, FENTON WS: What are theright targets for psychopharmacology? Science (2003) 299(1):350–351.
   PubMed Web of Science ®Google Scholar
• BUITELAARJK, MONTGOMERY SA, VAN ZWEIETEN-BOOT BJ: Conduct disorder: guidelines for investigating efficacy of pharmacological intervention. Eur. Neuropsychopharmacol (2003) 13:305–311.
   PubMed Web of Science ®Google Scholar
• AMAN MG, DE SMEDT G, DERIVAN A, LYONS B, FINDLING RL: Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am. .1. Psychiatry (2002) 159:1337–1346.
   Google Scholar
• GERARDIN P, COHEN D, MAZET P, FLAMENT M: Drug treatment of conduct disorder in young people. Eur. Neuropsychopharmacol (2002) 12:361–370.
   PubMed Web of Science ®Google Scholar
• MOFFITT TE, CASPI A, HARRINGTON H, MILINE B: Males on the life-course persistent and adolescence-limited antisocial pathways: follow-up at age 26. Dev. Psychopathol (2002) 14:179–206.
   PubMed Web of Science ®Google Scholar
• WEISSMAN MM, WOLK S, WICKRAMARATNE P et al. Children with prepubertal-onset major depressive disorder and anxiety grown up. Arch. Gen. Psychiatry (1999) 56:794–801.
   PubMed Web of Science ®Google Scholar
• WICKRAMARATNE PJ, GREENWALD MA, WEISSAMN MM: Psychiatric disorders in the relatives of probands with prepubertal-onset or adolescent-onset major depression. Acad Child Adolesc. Psychiatry(2000) 39:1396–1405.
   PubMed Web of Science ®Google Scholar
• HOFSTRA MB, VAN DER ENDE J, VERHULST FC: Continuity and change of psychopathology from childhood into adulthood: a 14-year follow-up study. Am. Acad. Child Adolesc. Psychiatry (2000) 39:850–858.
   PubMed Web of Science ®Google Scholar
• HOFSTAR MB, VAN DER ENDE J, VERHULST FC: Child and adolescent problems predict DSM-IV disorders in adulthood: a 14-year follow-up of a Dutch epidemiological sample. I Am. Acad. Child Adolesc. Psychiatry (2002) 41:182–187.
   PubMed Web of Science ®Google Scholar
• FERDINAND RE VERHULST FC: Psychopathology from adolescence into
   Google Scholar
• •• young adulthood: an 8-year follow-up study. Am. J. Psychiatry (1995) 152:1586–1594.
   PubMed Web of Science ®Google Scholar
• LOEBER R: Development and risk factors of juvenile antisocial behavior and delinquency. Clin. Psycho]. Rev (1990) 10:1–41.
   Web of Science ®Google Scholar
• HARRINGTON R, FUDGE H, RUTTER M, PICKLES A, HILL J: Adult outcome of childhood and adolescent depression: Links with antisocial personality disorder. j. Am. Acad. Child Adolesc. Psychiatry(1991) 30:434–439.
   PubMed Web of Science ®Google Scholar
• BASSARATH L: Conduct disorder: a biopsychosocial review. Can. J. Psychiatry (2001) 46:609–616.
   PubMed Web of Science ®Google Scholar
• VIEMERO V: Factors in childhood that predict later criminal behavior. Aggressive Behavior (1996) 2:87–97.
   Google Scholar
• BABINSKI LM, HARTSOUGH CS, LAMBERT NM: Childhood conduct problems, hyperactivity-impulsivity, and inattention of adult criminal activity. Child Psycho]. Psychiatry (1999) 40:347–355.
   PubMed Web of Science ®Google Scholar
• LYNAM DR: Early identification of chronic offenders: who is the fledging psychopath? Psycho]. Bull. (1996) 120:209–234.
   Google Scholar
• MINEKA S, WATSON D, CLARK LA: Comorbidity of anxiety and unipolar mood disorders. Ann. Rev Psycho]. (1998) 49:377–412.
   PubMed Web of Science ®Google Scholar
• NAGIN D, TREMBLAY RE: Analyzing developmental trajectories of distinct but related behaviors: a group-based method. Psycho]. Methods (2001) 6:18–34.
   PubMed Web of Science ®Google Scholar
• TARTER RE, VANUYKOV MM, GIANCOLA PR et al.: Etiology of early age onset substance use disorder, a maturational perspective. Dev. Psychopathol. (1999) 11:657–683.
   PubMed Web of Science ®Google Scholar
• TAYLOR E. Developmental neuropsychopathology of attention deficit and impulsiveness. Dev. Psychopathol. (1999) 11:607–628.
   PubMed Web of Science ®Google Scholar
• BIEDERMAN J, NEWCORN J, SPRICH S: Comorbidity of attention deficit hyperactivity disorder (ADHD). Am. J. Psychiatry (1991) 138:564–577.
   Google Scholar
• MOFFITT T: Adolescent-limited and life-course-persistent antisocial behavior: a developmental taxonomy. Psycho]. Rep. (1993) 100:674–701.
   Google Scholar
• ••Suggests a possibility of two subtypes of CD.
   Google Scholar
• HARADA Y, SATOH Y, SAKUMA A et al.:Behavioral and developmental disorders among conduct disorder. Psychiatry Clin. Neurosci. (2002) 56:621–625.
   PubMedGoogle Scholar
• STEWART M, CUMMINGS C, SINGERS, DeBOIS C: The overlap between hyperactive and unsocialized aggressive children. I Child Psycho]. Psychiatry (1981) 22:35–45.
   PubMed Web of Science ®Google Scholar
• HETTEMA JM, PRESCOTT CA, KENDLER K: The effects of anxiety, substance use and conduct disorders on risk of major depressive disorder. Psycho]. Med. (2003) 33:14–1432.
   Web of Science ®Google Scholar
• PRESKORN S, BAKER B: The overlap ofDSM-IV syndromes: potential implications for the practice of polypsychopharmacology, psychiatric drug development, and human genome project. J. Psychiatr. Pract. (2002) 8:170–177.
   PubMedGoogle Scholar
• VAN PRAAG H: Over the mainstream: diagnostic requirements for biological psychiatric research. Psychiatry Res. (1997) 72:201–212.
   PubMed Web of Science ®Google Scholar
• •Outlines some limitation of current diagnostic systems from the research perspective. AffiliationOleg V Tcheremissine MDI, Don R Cherek PhD& Scott D Lane PhD tAuthor for correspondence Department of Psychiatry and Behavioural Science, University of Texas Health Science Center - Houston, 1300 Moursund Street, Houston, TX 77030–3497, USA Tel: +1 (713) 500 2869; Fax: +1 (713) 500 2618; E-mail: [email protected]
   Google Scholar